Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Metastatic Castrate- Resistant Prostate Cancer”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT02215096
What this trial is testing

Dose-finding Study of GSK2636771 When Administered in Combination With Enzalutamide in Male Subjects With Metastatic Castration-Resistant Prostate Cancer

Who this might be right for
Neoplasms
GlaxoSmithKline 37
Testing effectiveness (Phase 2)Ended earlyNCT03442556
What this trial is testing

Docetaxel, Carboplatin, and Rucaparib Camsylate in Treating Patients With Metastatic Castration Resistant Prostate Cancer With Homologous Recombination DNA Repair Deficiency

Who this might be right for
ATM Gene MutationBRCA1 Gene MutationBRCA2 Gene Mutation+7 more
University of Washington 18
Early research (Phase 1)Study completedNCT02705469
What this trial is testing

ZEN003694 in Patients With Metastatic Castration-Resistant Prostate Cancer

Who this might be right for
Metastatic Castration-Resistant Prostate Cancer
Zenith Epigenetics 44
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06827080
What this trial is testing

Study on the Safety, Tolerability, and Preliminary Efficacy of 161Tb-NYM032 in Patients with Metastatic Castration-Resistant Prostate Cancer

Who this might be right for
Metastatic Castration-resistant Prostate Cancer, MCRPCCancer
Zhengguo Chen 15
Testing effectiveness (Phase 2)Study completedNCT01683994
What this trial is testing

Cabozantinib Plus Docetaxel and Prednisone for Advanced Prostate Cancer

Who this might be right for
Prostatic Neoplasms
National Cancer Institute (NCI) 49
Large-scale testing (Phase 3)Study completedNCT00003343
What this trial is testing

Chemotherapy in Treating Patients Who Have Metastatic Prostate Cancer

Who this might be right for
Prostate Cancer
Pfizer 525
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07793435
What this trial is testing

A Phase 1/2 Trial of ADI-212 in mCRPC

Who this might be right for
Prostate Cancer Metastatic
Adicet Therapeutics 12
Testing effectiveness (Phase 2)Study completedNCT01812746
What this trial is testing

Determine the Safety and Efficacy of BIND-014 (Docetaxel Nanoparticles for Injectable Suspension), Administered to Patients With Metastatic Castration-Resistant Prostate Cancer

Who this might be right for
CRPCProstate Cancer
BIND Therapeutics 42
Not applicableStudy completedNCT01160705
What this trial is testing

Biomarkers of Response to Taxotere in HRPC. ICORG 08-08, V2

Who this might be right for
Metastatic CancerProstate Cancer
Cancer Trials Ireland 73
Testing effectiveness (Phase 2)Study completedNCT03101046
What this trial is testing

Treatment of Metastatic Castrate Resistant Prostate Cancer Patients According to Circulating Tumor Cells Kinetic

Who this might be right for
Prostate CarcinomaCastration-resistant Prostate CancerCirculating Tumor Cells+1 more
UNICANCER 40
Testing effectiveness (Phase 2)Study completedNCT01091103
What this trial is testing

Determine Effect of Enzalutamide (MDV3100) on the Androgen Signaling Pathway in Correlation With the Anti-tumor Effects of Enzalutamide

Who this might be right for
Metastatic Progressive Castration-resistant Prostate Cancer
Pfizer 60
Testing effectiveness (Phase 2)Ended earlyNCT05917470
What this trial is testing

A Clinical Study of ONCT-534 in Subjects With Metastatic Castration-resistant Prostate Cancer.

Who this might be right for
Metastatic Castration-resistant Prostate Cancer
Oncternal Therapeutics, Inc 21
Early research (Phase 1)Study completedNCT06377683
What this trial is testing

Clinical Evaluation of 177Lu-DansyI-PSMA (LNC1011) in Patients With Metastatic Castration-Resistant Prostate Cancer

Who this might be right for
Metastatic Castration-resistant Prostate Cancer, mCRPC
The First Affiliated Hospital of Xiamen University 8
Early research (Phase 1)Study completedNCT00415779
What this trial is testing

ZANTE: Zometa and Taxotere in Hormone Refractory Prostate Cancer

Who this might be right for
Metastatic Prostate Cancer
National Cancer Institute, Naples 36
Large-scale testing (Phase 3)Looking for participantsNCT06629779
What this trial is testing

Learn How PF-06821497 (Mevrometostat) Works in Men With Metastatic Castration-resistant Prostate Cancer.

Who this might be right for
Metastatic Castration-Resistant Prostate Cancer
Pfizer 900
Testing effectiveness (Phase 2)Study completedNCT02346526
What this trial is testing

A Biomarker Study of Standard-of-care Radium-223 Chloride for Metastatic Castration-resistant Prostate Cancer

Who this might be right for
Prostate CancerCastration-resistant Prostate CancerCastration-resistant Prostate Cancer Metastatic to Bone
Massachusetts General Hospital 22
Large-scale testing (Phase 3)Looking for participantsNCT06585007
What this trial is testing

Metastasis-directed Therapy in Oligoprogressive Castration-refractory Prostate Cancer

Who this might be right for
Castration-resistant Prostate CancerOligoprogressive
Universitaire Ziekenhuizen KU Leuven 246
Testing effectiveness (Phase 2)Ended earlyNCT04458311
What this trial is testing

Abiraterone Acetate in Combination With Tildrakizumab

Who this might be right for
Metastatic Castration Resistant Prostate Cancer
Institute of Cancer Research, United Kingdom 13
Large-scale testing (Phase 3)Active Not RecruitingNCT03574571
What this trial is testing

Test Radium-223 With Docetaxel in Patients With Prostate Cancer

Who this might be right for
Prostate Cancer
Memorial Sloan Kettering Cancer Center 732
Testing effectiveness (Phase 2)WithdrawnNCT02793765
What this trial is testing

Docetaxel Followed by Provenge in Metastatic Prostate Cancer

Who this might be right for
Prostate Cancer
The University of Texas Health Science Center, Houston
Next Page